SFB1399 grows and two new sub-projects have been included.
C07 and C08 are the new additions to the SFB1399 with immediate effect. Accordingly, two new Principle Investigators Dr. Filippo Beleggia and Dr. Johannes Brägelmann have joined.
Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer
c/o Department of Translational Genomics
University of Cologne
50931 Cologne, Germany